Connecticut Innovations, the state’s quasi-public venture capital arm, invested $9.4 million in Connecticut companies during the third quarter of the 2021 fiscal year, which ended March 31.
CI’s total third-quarter investments amounted to $2.2 million more than the venture fund invested in fiscal 2021’s second quarter.
Bioscience and healthcare information companies received the greatest share of CI’s third-quarter investments with $6.5 million, followed by IT companies, which received $1.8 million.Â
We continue to see investment opportunities across all technology sectors and look forward to accelerating momentum through the end of the fiscal year,” David Wurzer, CI’s executive vice president and chief investment officer, said.
CI’s investments for fiscal 2021’s second quarter include:
Â
Â
